Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus

Fig. 2

Comparison of the levels of urinary podocyte-derived MPs from SLE patients group and healthy control group. a Urinary MPs from a SLE patient were observed by transmission electron microscopy (× 40000). b The absolute numbers of podocyte-derived MPs in two groups. c Analysis of urinary podocyte-derived MPs in two subgroups of SLE patients (SLE without LN and SLE with LN) and healthy controls. d Analysis of podocyte and MPs in patients with SLE for different disease activity (defined by SLEDAI score) and healthy control. (e) Analysis of podocyte and MPs in patients with SLE for different ANA titer and healthy control. Data are shown as boxes displaying median with interquartile range. HC, healthy control; LN, lupus nephritis. *P < 0.05; **P < 0.01

Back to article page